AU Patent

AU2017311412A1 — Methods and compositions for treatment of epileptic disorders

Assigned to Ovid Therapeutics Inc · Expires 2019-02-07 · 7y expired

What this patent protects

Use of allosteric modulators and/or gaboxadol for the treatment of epileptic disorders in a subject in need thereof.

USPTO Abstract

Use of allosteric modulators and/or gaboxadol for the treatment of epileptic disorders in a subject in need thereof.

Drugs covered by this patent

Patent Metadata

Patent number
AU2017311412A1
Jurisdiction
AU
Classification
—
Expires
2019-02-07
Drug substance claim
No
Drug product claim
No
Assignee
Ovid Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.